Börje Wernersson
AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Gastroesophageal reflux and treatments, Helicobacter pylori-related gastroenterology studies, Eosinophilic Esophagitis, Gastrointestinal motility and disorders, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Validation of the GerdQ questionnaire for the diagnosis of gastro‐oesophageal reflux disease(2013)250 cited
- → Epidemiology of Peptic Ulcer Disease: Endoscopic Results of the Systematic Investigation of Gastrointestinal Disease in China(2010)148 cited
- → Limited Ability of the Proton-Pump Inhibitor Test to Identify Patients With Gastroesophageal Reflux Disease(2012)126 cited
- → Regurgitation Is Less Responsive to Acid Suppression Than Heartburn in Patients With Gastroesophageal Reflux Disease(2012)105 cited
- → Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: The systematic investigation of gastrointestinal diseases in China (SILC)(2010)83 cited
- → Dyspepsia and irritable bowel syndrome in China: a population‐based endoscopy study of prevalence and impact(2010)78 cited
- → Symptom Overlap Between Postprandial Distress and Epigastric Pain Syndromes of the Rome III Dyspepsia Classification(2013)73 cited
- → Partial symptom‐response to proton pump inhibitors in patients with non‐erosive reflux disease or reflux oesophagitis – a post hoc analysis of 5796 patients(2012)69 cited
- → Epithelial Thickness is a Marker of Gastroesophageal Reflux Disease(2016)47 cited
- → Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study(2013)28 cited